Selecting first-line treatment for patients with chronic lymphocytic leukemia (CLL) in 2019

Chairs: John Gribben and Paolo Ghia

Considerations for the management of previously untreated patients with CLL in light of recent data updates - Paolo Ghia

After participating in this broadcast you should be able to:
- Describing key considerations when selecting first-line treatment for patients with CLL.